* Not logged in  
Login :: Register :: Home 
RSS Feeds :: Classifieds
Contact Us :: About :: Help 
All Categories
Stock Market News 
(Sub Categories)
  By Industry 
  By Company Name 
  By Ticker 
(No Feeds)
SHARE
Mark Dunn Heart attack risk: Vioxx makers face $200m compo bill
(Moreover) Melbourne precedent: A Federal Court has awarded significant compensation against Vioxx-maker Merck after a Melbourne man suffered a heart attack. Source: AP The arthritis drug Vioxx has been found not fit for sale, allegedly doubling the risk of hea
Articles from: Merck and Co news (Moreover)  Subscribe
... More from Category: Stock Market News / By Company Name
Next Page  
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued For Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
Warner Chilcott Sued for Denying Employees Overtime Pay (more)2012 01 30
4 Blue Chip Dividend Stocks For The Next Decade (more)2012 01 30
Merck Gives Grant to Sarcoma Alliance to Update Peer-to-Peer Network (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Chinese Pharmaceutical Market 2012-2022 (more)2012 01 30
Biobanking for Medicine: Technology and Market 2012-2022 (more)2012 01 30
Next Page  


HDLNS (dot com) - News Headlines Updated 24 Hours a Day.
"HDLNS (dot com)" is a trademark of Avant Garde Creatives, Inc. This site, its design, and all associated software © 2005, Avant Garde Creatives, Inc. All rights reserved. All content is provided for your personal, non-commercial use, in accordance with the terms of its providers.
HDLNS (dot com) is search engine sitemap friendly. Classifieds